<p>Plasma concentrations (µg/l) are depicted for each individual patient in time (h). Individual patients are marked with a colour code and maker: patient 1: 0, black; patient 2 ▵, blue and patient 3: ▿,red.</p
The effects of loading doses and probenecid coadministration on oseltamivir pharmacokinetics at four...
<p>Distribution of efavirenz plasma concentrations according to the therapeutic range at each sampli...
The visual predictive checks were simulated for 1,000 patients and are shown for all 7 drugs and 9 l...
<p>Plasma concentrations (µg/l) are depicted for each individual patient in time (h). Individual pat...
<p>Panel A shows the pharmacokinetics for twice-a-day intake for 5 days and the panel B once a day i...
<p>Area under the concentration versus time curve (AUC<sub>0t</sub>) is indicated. Values represent ...
<p>Gray line, patients without hyperbilirubinemia (N = 20); black dotted line, patients with hyperbi...
Oseltamivir and oseltamivir carboxylate concentrations were measured in venous plasma, venous blood,...
<p>Dashed lines represent the upper and lower limits of the therapeutic window of ATV concentrations...
<p>Accuracy and precision values of the HPLC-MS/MS method for the determination of oseltamivir in ra...
<p>Each panel represents the variation of efficacy depending on the therapy initiation time relative...
AbstractA simple, precise and rapid liquid chromatography–tandem mass spectrometry (LC–MS/MS) method...
<p>For clarity, the OC concentrations from the exit limb (e) to the effluent bags are shown for Pati...
<p>Grouping of patients was based on the number of days from symptom onset to oseltamivir administra...
<p>Distribution of tenofovir, emtricitabine and rilpivirine plasma concentrations at different time-...
The effects of loading doses and probenecid coadministration on oseltamivir pharmacokinetics at four...
<p>Distribution of efavirenz plasma concentrations according to the therapeutic range at each sampli...
The visual predictive checks were simulated for 1,000 patients and are shown for all 7 drugs and 9 l...
<p>Plasma concentrations (µg/l) are depicted for each individual patient in time (h). Individual pat...
<p>Panel A shows the pharmacokinetics for twice-a-day intake for 5 days and the panel B once a day i...
<p>Area under the concentration versus time curve (AUC<sub>0t</sub>) is indicated. Values represent ...
<p>Gray line, patients without hyperbilirubinemia (N = 20); black dotted line, patients with hyperbi...
Oseltamivir and oseltamivir carboxylate concentrations were measured in venous plasma, venous blood,...
<p>Dashed lines represent the upper and lower limits of the therapeutic window of ATV concentrations...
<p>Accuracy and precision values of the HPLC-MS/MS method for the determination of oseltamivir in ra...
<p>Each panel represents the variation of efficacy depending on the therapy initiation time relative...
AbstractA simple, precise and rapid liquid chromatography–tandem mass spectrometry (LC–MS/MS) method...
<p>For clarity, the OC concentrations from the exit limb (e) to the effluent bags are shown for Pati...
<p>Grouping of patients was based on the number of days from symptom onset to oseltamivir administra...
<p>Distribution of tenofovir, emtricitabine and rilpivirine plasma concentrations at different time-...
The effects of loading doses and probenecid coadministration on oseltamivir pharmacokinetics at four...
<p>Distribution of efavirenz plasma concentrations according to the therapeutic range at each sampli...
The visual predictive checks were simulated for 1,000 patients and are shown for all 7 drugs and 9 l...
DOI
Add to ORKG